Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Cg Oncology Inc shares valued at $851,797 were sold by Mulay James on Sep 05 ’25. At $31.53 per share, Mulay James sold 27,015 shares. The insider’s holdings dropped to 0 shares worth approximately $0.0 following the completion of this transaction.
Also, JAMES MULAY purchased 27,015 shares, netting a total of over 835,844 in proceeds.
Before that, Song Hong Fang had sold 100,000 shares from its account. In a trade valued at $2,779,542, the Director traded Cg Oncology Inc shares for $27.80 each. Upon closing the transaction, the insider’s holdings decreased to 100,000 shares, worth approximately $96.29 million.
As published in their initiating research note from Piper Sandler on August 19, 2025, Cg Oncology Inc [CGON] has been an Overweight and the price target has been revised to $55. As of May 02, 2025, JP Morgan has initiated its “an Overweight” rating for CGON. Earlier on April 16, 2025, Scotiabank initiated its rating. Their recommendation was “a Sector perform” for CGON stock.
Analyzing CGON Stock Performance
On last trading session, Cg Oncology Inc [NASDAQ: CGON] plunged -1.40% to $33.16. The stock’s lowest price that day was $32.66, but it reached a high of $34.63 in the same session. During the last five days, there has been a surge of approximately 7.18%. Over the course of the year, Cg Oncology Inc shares have dropped approximately -12.58%. Shares of the company reached a 52-week high of $34.74 on 09/10/25 and a 52-week low of $14.80 on 04/09/25.
Support And Resistance Levels for Cg Oncology Inc (CGON)
According to the 24-hour chart, there is a support level at 32.34, which, if violated, would cause prices to drop to 31.51. In the upper region, resistance lies at 34.31. The next price resistance is at 35.45. RSI (Relative Strength Index) is 71.93 on the 14-day chart, showing overbought technical sentiment.
Is Cg Oncology Inc subject to short interest?
Stocks of Cg Oncology Inc saw a sharp steep in short interest on 2025-08-29 dropping by -0.77 million shares to 10.23 million. Data from Yahoo Finance shows that the short interest on 2025-07-31 was 11.0 million shares. A decline of -7.54% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 15.91 of the overall float, the days-to-cover ratio (short ratio) decline to 15.91.
Which companies own the most shares of Cg Oncology Inc (CGON)?
In terms of Cg Oncology Inc share price expectations, FactSet research, analysts set an average price target of 55 in the next 12 months, up nearly 63.54% from the previous closing price of $33.63. Analysts anticipate Cg Oncology Inc stock to reach 55 by 2025, with the lowest price target being 55. In spite of this, 4 analysts ranked Cg Oncology Inc stock as Buy at the end of 2025.
